This announcement is a separate document:
千红制药:北京大成(南京)律师事务所关于常州千红生化制药股份有限公司2023年度股东大会的法律意见书
Changzhou Qianhong Biopharma: Legal Opinion of Beijing Dacheng (Nanjing) Law Firm on the 2023 Annual General Meeting of Shareholders of Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.